Why is Transgene Biotek falling/rising?

As of 31-Oct, Transgene Biotek Ltd's stock price is currently at Rs. 3.78, reflecting an increase of Rs. 0.04 or 1.07%. The stock has recently shown signs of recovery after two consecutive days of decline, outperforming its sector by 2.34%. However, it has also hit a new 52-week low of Rs. 3.21 today. Despite this short-term gain, the stock has experienced significant declines over the past week, month, and year, with returns of -11.68%, -8.92%, and -46.00%, respectively, indicating a challenging performance relative to the benchmark Sensex, which has shown positive returns over the same periods. The stock is currently trading below all its moving averages, suggesting a bearish trend, although rising investor participation, with a delivery volume increase of 223.78%, indicates some renewed interest.
In the broader market context, while Transgene Biotek has seen a slight uptick today, its overall performance remains weak compared to the Sensex, which has gained 3.65% over the past month and 5.73% over the past year. The stark contrast in performance highlights the stock's struggles, particularly with a year-to-date decline of 44.66% compared to the Sensex's positive return of 7.42%. This underperformance may be contributing to investor caution, despite today's positive movement, as the stock continues to grapple with a challenging market environment.